171 related articles for article (PubMed ID: 16040151)
1. Interleukin-6 plays a crucial role in the hepatic expression of SOCS3 during acute inflammatory processes in vivo.
Yang XP; Schaper F; Teubner A; Lammert F; Heinrich PC; Matern S; Siewert E
J Hepatol; 2005 Oct; 43(4):704-10. PubMed ID: 16040151
[TBL] [Abstract][Full Text] [Related]
2. Expression of STAT3 and SOCS3 in pancreatic acinar cells.
Vona-Davis LC; Frankenberry KA; Waheed U; Peterson E; McFadden DW
J Surg Res; 2005 Jul; 127(1):14-20. PubMed ID: 15893771
[TBL] [Abstract][Full Text] [Related]
3. Hepatic cytochrome P450 down-regulation during aseptic inflammation in the mouse is interleukin 6 dependent.
Siewert E; Bort R; Kluge R; Heinrich PC; Castell J; Jover R
Hepatology; 2000 Jul; 32(1):49-55. PubMed ID: 10869288
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 regulates hepatic transporters during acute-phase response.
Siewert E; Dietrich CG; Lammert F; Heinrich PC; Matern S; Gartung C; Geier A
Biochem Biophys Res Commun; 2004 Sep; 322(1):232-8. PubMed ID: 15313196
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoids increase interleukin-6-dependent gene induction by interfering with the expression of the suppressor of cytokine signaling 3 feedback inhibitor.
Dittrich A; Khouri C; Sackett SD; Ehlting C; Böhmer O; Albrecht U; Bode JG; Trautwein C; Schaper F
Hepatology; 2012 Jan; 55(1):256-66. PubMed ID: 21898505
[TBL] [Abstract][Full Text] [Related]
6. IL-1 beta mediates leptin induction during inflammation.
Faggioni R; Fantuzzi G; Fuller J; Dinarello CA; Feingold KR; Grunfeld C
Am J Physiol; 1998 Jan; 274(1):R204-8. PubMed ID: 9458919
[TBL] [Abstract][Full Text] [Related]
7. Attenuated fever in rats during late pregnancy is linked to suppressed interleukin-6 production after localized inflammation with turpentine.
Aguilar-Valles A; Poole S; Mistry Y; Williams S; Luheshi GN
J Physiol; 2007 Aug; 583(Pt 1):391-403. PubMed ID: 17556393
[TBL] [Abstract][Full Text] [Related]
8. IL-6 promotes acute and chronic inflammatory disease in the absence of SOCS3.
Croker BA; Kiu H; Pellegrini M; Toe J; Preston S; Metcalf D; O'Donnell JA; Cengia LH; McArthur K; Nicola NA; Alexander WS; Roberts AW
Immunol Cell Biol; 2012 Jan; 90(1):124-9. PubMed ID: 21519345
[TBL] [Abstract][Full Text] [Related]
9. Suppressor of cytokine signaling 3 (SOCS3) limits damage-induced crypt hyper-proliferation and inflammation-associated tumorigenesis in the colon.
Rigby RJ; Simmons JG; Greenhalgh CJ; Alexander WS; Lund PK
Oncogene; 2007 Jul; 26(33):4833-41. PubMed ID: 17297444
[TBL] [Abstract][Full Text] [Related]
10. SOCS3 negatively regulates IL-6 signaling in vivo.
Croker BA; Krebs DL; Zhang JG; Wormald S; Willson TA; Stanley EG; Robb L; Greenhalgh CJ; Förster I; Clausen BE; Nicola NA; Metcalf D; Hilton DJ; Roberts AW; Alexander WS
Nat Immunol; 2003 Jun; 4(6):540-5. PubMed ID: 12754505
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-10 anti-inflammatory response to Borrelia burgdorferi, the agent of Lyme disease: a possible role for suppressors of cytokine signaling 1 and 3.
Dennis VA; Jefferson A; Singh SR; Ganapamo F; Philipp MT
Infect Immun; 2006 Oct; 74(10):5780-9. PubMed ID: 16988256
[TBL] [Abstract][Full Text] [Related]
12. The dual function of hepatic SOCS3 in insulin resistance in vivo.
Torisu T; Sato N; Yoshiga D; Kobayashi T; Yoshioka T; Mori H; Iida M; Yoshimura A
Genes Cells; 2007 Feb; 12(2):143-54. PubMed ID: 17295835
[TBL] [Abstract][Full Text] [Related]
13. Suppressor of cytokine signalling-3 at pathological levels does not regulate lipopolysaccharide or interleukin-10 control of tumour necrosis factor-alpha production by human monocytes.
Prêle CM; Keith-Magee AL; Yerkovich ST; Murcha M; Hart PH
Immunology; 2006 Sep; 119(1):8-17. PubMed ID: 16925527
[TBL] [Abstract][Full Text] [Related]
14. Muscle-specific deletion of SOCS3 does not reduce the anabolic response to leucine in a mouse model of acute inflammation.
Caldow MK; Ham DJ; Chee A; Trieu J; Naim T; Stapleton DI; Swiderski K; Lynch GS; Koopman R
Cytokine; 2017 Aug; 96():274-278. PubMed ID: 28554144
[TBL] [Abstract][Full Text] [Related]
15. IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages.
Yasukawa H; Ohishi M; Mori H; Murakami M; Chinen T; Aki D; Hanada T; Takeda K; Akira S; Hoshijima M; Hirano T; Chien KR; Yoshimura A
Nat Immunol; 2003 Jun; 4(6):551-6. PubMed ID: 12754507
[TBL] [Abstract][Full Text] [Related]
16. IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro.
Brand S; Dambacher J; Beigel F; Zitzmann K; Heeg MH; Weiss TS; Prüfer T; Olszak T; Steib CJ; Storr M; Göke B; Diepolder H; Bilzer M; Thasler WE; Auernhammer CJ
Am J Physiol Gastrointest Liver Physiol; 2007 Apr; 292(4):G1019-28. PubMed ID: 17204547
[TBL] [Abstract][Full Text] [Related]
17. Selective involvement of interleukin-6 in the transcriptional activation of the suppressor of cytokine signaling-3 in the brain during systemic immune challenges.
Lebel E; Vallières L; Rivest S
Endocrinology; 2000 Oct; 141(10):3749-63. PubMed ID: 11014231
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-6 deficiency accelerates cisplatin-induced acute renal failure but not systemic injury.
Mitazaki S; Kato N; Suto M; Hiraiwa K; Abe S
Toxicology; 2009 Nov; 265(3):115-21. PubMed ID: 19833167
[TBL] [Abstract][Full Text] [Related]
19. Regulation of liver regeneration and hepatocarcinogenesis by suppressor of cytokine signaling 3.
Riehle KJ; Campbell JS; McMahan RS; Johnson MM; Beyer RP; Bammler TK; Fausto N
J Exp Med; 2008 Jan; 205(1):91-103. PubMed ID: 18158318
[TBL] [Abstract][Full Text] [Related]
20. Molecular dissection of gp130-dependent pathways in hepatocytes during liver regeneration.
Dierssen U; Beraza N; Lutz HH; Liedtke C; Ernst M; Wasmuth HE; Trautwein C
J Biol Chem; 2008 Apr; 283(15):9886-95. PubMed ID: 18216023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
